NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Tuberculosis



Researchers from University of Pecs, Medical Department provide details of new studies and findings in the area of tuberculosis



April 8th, 2008

"Tuberculosis (TB) is one of the most common major infectious diseases. In humans, acquired protective immunity to Mycobacterium tuberculosis depends on T-cells and involves multiple T-cell subsets; however, the pathways used by T-cells to restrict the growth of M. tuberculosis are poorly understood," scientists in Pecs, Hungary report.

"To investigate the possible role of V delta 2+T-cells and regulatory T-cells in the immune response to M. tuberculosis. As V delta 2+T-cell function has been shown to be impaired in patients with M. tuberculosis infection, we investigated the percentage of perforin and Fas ligand (FasL) positive V delta 2+T-cells and the possible role...


Source: TB & Outbreaks Week (2008-04-08)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login